Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for PROCEPT BioRobotics Corporation (PRCT : NSDQ)
 
 • Company Description   
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Number of Employees: 234

 
 • Price / Volume Information   
Yesterday's Closing Price: $40.00 Daily Weekly Monthly
20 Day Moving Average: 349,033 shares
Shares Outstanding: 44.17 (millions)
Market Capitalization: $1,766.93 (millions)
Beta:
52 Week High: $47.73
52 Week Low: $15.38
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 6.50% 16.22%
12 Week 85.01% 94.78%
Year To Date 59.94% 86.43%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
900 ISLAND DRIVE
-
REDWOOD CITY,CA 94065
USA
ph: 650-232-7200
fax: -
ir@procept-biorobotics.com http://www.procept-biorobotics.com
 
 • General Corporate Information   
Officers
Reza Zadno - President; Chief Executive Officer and Director
Frederic Moll - Director and Chair of the Board
Kevin Waters - Chief Financial Officer
Antal Desai - Director
Amy Dodrill - Director

Peer Information
PROCEPT BioRobotics Corporation (ABMD)
PROCEPT BioRobotics Corporation (DMDS)
PROCEPT BioRobotics Corporation (CPWY.)
PROCEPT BioRobotics Corporation (EQUR)
PROCEPT BioRobotics Corporation (ECIA)
PROCEPT BioRobotics Corporation (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 74276L105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 44.17
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,766.93 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.49 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.86 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.96
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 7.14%
Sales Growth
vs. Year Ago Period: 97.40%
vs. Previous Quarter: 40.04%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - 20.87
12/31/21 - 20.08
09/30/21 - 23.94
Quick Ratio
03/31/22 - 20.01
12/31/21 - 19.27
09/30/21 - 23.21
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -173.62
09/30/21 - -
Book Value
03/31/22 - 5.72
12/31/21 - 6.14
09/30/21 - 6.70
Inventory Turnover
03/31/22 - -
12/31/21 - 2.37
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.20
12/31/21 - 0.19
09/30/21 - 0.18
Debt-to-Capital
03/31/22 - 17.00
12/31/21 - 16.17
09/30/21 - 15.31
 

Powered by Zacks Investment Research ©